Literature DB >> 21742492

Peptoid ligands that bind selectively to phosphoproteins.

Di Cai1, A-Young Lee, Cheng-Ming Chiang, Thomas Kodadek.   

Abstract

Synthetic equivalents of phosphoprotein-specific antibodies would be valuable reagents for biological research, since these antibodies can often be difficult to produce. Protein phosphorylation is thought to result in significant conformational changes in most substrate proteins. Therefore, one approach might be to simply screen combinatorial libraries for ligands to the phosphorylated state in the hope of isolating a ligand that binds to a pocket created by the conformational shift. In this study, we probe this strategy by screening a peptoid library for ligands to the phosphorylated form of the Brd4 chromatin adaptor and transcriptional coactivator protein. We find that peptoids with high selectivity for binding to the phosphorylation form of Brd4 can indeed be isolated in this screen. Moreover, these ligands do not bind promiscuously to other phospho-proteins. However, attempts to employ these reagents as antibody substitutes in an immunoaffinity purification-like application showed that they do not perform as well as bona fide antibodies and that significant optimization will be required. This study highlights the potential and current limitations of a naïve library screening strategy for phosphoprotein-specific antibody surrogates. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742492      PMCID: PMC3591469          DOI: 10.1016/j.bmcl.2011.06.011

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  22 in total

1.  Microwave-assisted solid-phase synthesis of peptoids.

Authors:  Hernando J Olivos; Prasanna G Alluri; M Muralidhar Reddy; Derek Salony; Thomas Kodadek
Journal:  Org Lett       Date:  2002-11-14       Impact factor: 6.005

2.  Production of phosphorylation state-specific antibodies.

Authors:  A J Czernik; J A Girault; A C Nairn; J Chen; G Snyder; J Kebabian; P Greengard
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

3.  Expression and purification of general transcription factors by FLAG epitope-tagging and peptide elution.

Authors:  C M Chiang; R G Roeder
Journal:  Pept Res       Date:  1993 Mar-Apr

4.  Isolation of mouse TFIID and functional characterization of TBP and TFIID in mediating estrogen receptor and chromatin transcription.

Authors:  S Y Wu; M C Thomas; S Y Hou; V Likhite; C M Chiang
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

5.  Antibodies directed against phosphothreonine residues as potent tools for studying protein phosphorylation.

Authors:  D Heffetz; M Fridkin; Y Zick
Journal:  Eur J Biochem       Date:  1989-06-15

6.  Bromodomain factor 1 (Bdf1) is phosphorylated by protein kinase CK2.

Authors:  Chika Sawa; Eduard Nedea; Nevan Krogan; Tadashi Wada; Hiroshi Handa; Jack Greenblatt; Stephen Buratowski
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

7.  Peptoids: a modular approach to drug discovery.

Authors:  R J Simon; R S Kania; R N Zuckermann; V D Huebner; D A Jewell; S Banville; S Ng; L Wang; S Rosenberg; C K Marlowe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

8.  Periodate-triggered cross-linking of DOPA-containing peptide-protein complexes.

Authors:  Lyle Burdine; Thomas G Gillette; Hai-Jun Lin; Thomas Kodadek
Journal:  J Am Chem Soc       Date:  2004-09-22       Impact factor: 15.419

9.  Unique TATA-binding protein-containing complexes and cofactors involved in transcription by RNA polymerases II and III.

Authors:  C M Chiang; H Ge; Z Wang; A Hoffmann; R G Roeder
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

10.  Selective inhibition of BET bromodomains.

Authors:  Panagis Filippakopoulos; Jun Qi; Sarah Picaud; Yao Shen; William B Smith; Oleg Fedorov; Elizabeth M Morse; Tracey Keates; Tyler T Hickman; Ildiko Felletar; Martin Philpott; Shonagh Munro; Michael R McKeown; Yuchuan Wang; Amanda L Christie; Nathan West; Michael J Cameron; Brian Schwartz; Tom D Heightman; Nicholas La Thangue; Christopher A French; Olaf Wiest; Andrew L Kung; Stefan Knapp; James E Bradner
Journal:  Nature       Date:  2010-09-24       Impact factor: 49.962

View more
  9 in total

1.  BRD4 Phosphorylation Regulates HPV E2-Mediated Viral Transcription, Origin Replication, and Cellular MMP-9 Expression.

Authors:  Shwu-Yuan Wu; Dawn Sijin Nin; A-Young Lee; Scott Simanski; Thomas Kodadek; Cheng-Ming Chiang
Journal:  Cell Rep       Date:  2016-07-28       Impact factor: 9.423

Review 2.  Phospho-BRD4: transcription plasticity and drug targeting.

Authors:  Cheng-Ming Chiang
Journal:  Drug Discov Today Technol       Date:  2016-07-18

3.  Conditional Human BRD4 Knock-In Transgenic Mouse Genotyping and Protein Isoform Detection.

Authors:  Michael Paul Lewis; Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Bio Protoc       Date:  2022-04-05

4.  Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.

Authors:  Pan Tang; Jifa Zhang; Jie Liu; Cheng-Ming Chiang; Liang Ouyang
Journal:  J Med Chem       Date:  2021-02-22       Impact factor: 7.446

Review 5.  Involvement of Brd4 in different steps of the papillomavirus life cycle.

Authors:  Thomas Iftner; Juliane Haedicke-Jarboui; Shwu-Yuan Wu; Cheng-Ming Chiang
Journal:  Virus Res       Date:  2016-12-10       Impact factor: 3.303

Review 6.  BET bromodomains as novel epigenetic targets for brain health and disease.

Authors:  Mandakini B Singh; Gregory C Sartor
Journal:  Neuropharmacology       Date:  2020-09-15       Impact factor: 5.250

Review 7.  From Synapse to Function: A Perspective on the Role of Neuroproteomics in Elucidating Mechanisms of Drug Addiction.

Authors:  Luis A Natividad; Matthew W Buczynski; Daniel B McClatchy; John R Yates
Journal:  Proteomes       Date:  2018-12-09

8.  A natural product targets BRD4 to inhibit phase separation and gene transcription.

Authors:  Cong Wang; Huasong Lu; Xiangzhong Liu; Xiang Gao; Wenjing Tian; Haifeng Chen; Yuhua Xue; Qiang Zhou
Journal:  iScience       Date:  2021-12-31

Review 9.  Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor.

Authors:  Na Liu; Rui Ling; Xiang Tang; Yunpeng Yu; Yuepeng Zhou; Deyu Chen
Journal:  Front Oncol       Date:  2022-03-21       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.